ACC.26 - This Market Watch episode from ACC.26 offers an unusually clear window into how one major device company is thinking about the future of interventional AF, from trial design to day-to-day practice. In an independent, editorially led discussion, host Brad Wilson speaks with Dr Brad Sutton, Chief Medical Officer for Atrial Fibrillation Solutions at Boston Scientific, about what CHAMPION-AF and the broader LAAC data set mean for operators at the table today.